Role of aquaporin 9 in cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes.

[1]  Jie Liu,et al.  Liver is a target of arsenic carcinogenesis. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  Ellen K Silbergeld,et al.  Arsenic exposure and prevalence of type 2 diabetes in US adults. , 2008, JAMA.

[3]  M. Richards,et al.  Identification and characterization of aquaporin-9 (AQP9) in porcine hepatic tissue and hepatocytes in monolayer culture. , 2007, Domestic animal endocrinology.

[4]  E. Füchtbauer,et al.  Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice , 2007, Proceedings of the National Academy of Sciences.

[5]  Y. Kwong,et al.  Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells. , 2007, Blood.

[6]  D. Sumi,et al.  Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. , 2007, Annual review of pharmacology and toxicology.

[7]  Te-Chang Lee,et al.  Enhanced Expression of Multidrug resistance-associated Protein 2 and Reduced Expression of Aquaglyceroporin 3 in an Arsenic-resistant Human Cell Line* , 2006, Journal of Biological Chemistry.

[8]  T. Ishii,et al.  Sulforaphane, an activator of Nrf2, suppresses cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes , 2006, FEBS letters.

[9]  J. Nezu,et al.  Organic anion transporting polypeptide-C mediates arsenic uptake in HEK-293 cells. , 2006, Journal of biomedical science.

[10]  N. LaRusso,et al.  Aquaporins in the hepatobiliary system , 2006, Hepatology.

[11]  E. Guallar,et al.  Arsenic Exposure and Type 2 Diabetes: A Systematic Review of the Experimental and Epidemiologic Evidence , 2005, Environmental health perspectives.

[12]  F. Lo Coco,et al.  Arsenic trioxide in the treatment of acute promyelocytic leukemia. A review of current evidence. , 2005, Haematologica.

[13]  Hiranmoy Bhattacharjee,et al.  Drug uptake and pharmacological modulation of drug sensitivity in leukemia by AQP9. , 2004, Biochemical and biophysical research communications.

[14]  P. Agre,et al.  Arsenic trioxide uptake by human and rat aquaglyceroporins. , 2004, Biochemical and biophysical research communications.

[15]  T. Rossman.  Mechanism of arsenic carcinogenesis: an integrated approach. , 2003, Mutation research.

[16]  Peter Agre,et al.  Aquaporin water channels: molecular mechanisms for human diseases1 , 2003, FEBS letters.

[17]  R N Ratnaike,et al.  Acute and chronic arsenic toxicity , 2003, Postgraduate medical journal.

[18]  T. Misaka,et al.  Aquaporin‐9 is expressed in a mucus‐secreting goblet cell subset in the small intestine , 2003, FEBS letters.

[19]  S. Hirano,et al.  Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells , 2003, Archives of Toxicology.

[20]  P. Agre,et al.  Aquaglyceroporin AQP9: Solute permeation and metabolic control of expression in liver , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  K. Dicke,et al.  Arsenic trioxide as effective therapy for relapsed acute promyelocytic leukemia. , 2002, Clinical journal of oncology nursing.

[22]  B. Rosen,et al.  Biochemistry of arsenic detoxification , 2002, FEBS letters.

[23]  M. Matsuda,et al.  Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9. , 2002, Diabetes.

[24]  I. Jaspers,et al.  The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. , 2002, Environmental health perspectives.

[25]  D. Nordstrom.  Worldwide Occurrences of Arsenic in Ground Water , 2002, Science.

[26]  D. Ribatti,et al.  Tissue Distribution and Membrane Localization of Aquaporin-9 Water Channel , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[27]  Guha Mazumder Dn.  Arsenic and liver disease. , 2001 .

[28]  M. Lieberman,et al.  The MRP2/cMOAT Transporter and Arsenic-Glutathione Complex Formation Are Required for Biliary Excretion of Arsenic* , 2000, The Journal of Biological Chemistry.

[29]  M. Matsuda,et al.  Aquaporin Adipose, a Putative Glycerol Channel in Adipocytes* , 2000, The Journal of Biological Chemistry.

[30]  S. Weremowicz,et al.  Functional and molecular characterization of the human neutral solute channel aquaporin-9. , 1999, American journal of physiology. Renal physiology.

[31]  M. Hediger,et al.  Molecular Characterization of a Broad Selectivity Neutral Solute Channel* , 1998, The Journal of Biological Chemistry.

[32]  F. Marumo,et al.  Cloning and functional expression of a new aquaporin (AQP9) abundantly expressed in the peripheral leukocytes permeable to water and urea, but not to glycerol. , 1998, Biochemical and biophysical research communications.

[33]  Y. Matsuzawa,et al.  Molecular cloning and expression of a novel human aquaporin from adipose tissue with glycerol permeability. , 1997, Biochemical and biophysical research communications.

[34]  I. Pastan,et al.  Expression of a multidrug resistance-adenosine deaminase fusion gene. , 1989, The Journal of biological chemistry.

[35]  F. Denizot,et al.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.

[36]  J. Kyhse-Andersen.  Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. , 1984, Journal of biochemical and biophysical methods.